Article
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Blood - 1 Mar 2007
Bossard Céline, Belhadj Karim, Reyes Felix, Martin-Garcia Nadine, Berger Françoise, Kummer Jean Alain, Brière Josette, Baglin Anne-Catherine, Cheze Stéphane, Bosq Jacques, Ribrag Vincent, Gisselbrecht Christian, Mounier Nicolas, Gaulard Philippe
Abstract excerpt
Nasal NK/T-cell lymphoma is a rare disease entity with a poor outcome. Expression of antiapoptotic proteins has not been extensively investigated in this entity. Forty-eight patients with nasal T/NK-cell lymphoma who received first-line polychemotherapy (n = 44) or chemoradiotherapy (n = 4) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.